$68.92
-0.150 (-0.217%)
At Close: Jun 23, 2026
Dow Jones' Strength Wavers Due To Recent Rise In Coronavirus Cases; Growth Stocks Lead Market
07:15pm, Wednesday, 01'st Jul 2020
The Dow Jones traded near break-even as the S&P; 500 and Nasdaq gained strength in heavy volume. A handful of Leaderboard stocks also traded in buy zones.
Will DexCom (DXCM) Beat Estimates Again in Its Next Earnings Report?
04:10pm, Wednesday, 01'st Jul 2020
DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
If You Invested $1,000 in Dexcom's IPO, This Is How Much Money You'd Have Now | The Motley Fool
11:28am, Wednesday, 01'st Jul 2020
Even small investments can have a big payoff down the road.
These stocks, including Tesla and Apple, are the real winners for the second quarter of 2020
10:24am, Wednesday, 01'st Jul 2020
A select group of stocks rose in the second quarter and for all of 2020.
BRIC Diabetes Care Devices Market (2020 to 2025) - High Prevalence of Diabetes Presents Opportunities
12:00am, Wednesday, 01'st Jul 2020
Dublin, July 01, 2020 (GLOBE NEWSWIRE) -- The "Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin...
DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know
09:50pm, Tuesday, 30'th Jun 2020
In the latest trading session, DexCom (DXCM) closed at $405.40, marking a +1.81% move from the previous day.
Top Stocks for July 2020
07:13pm, Tuesday, 30'th Jun 2020
The S&P; 500 Index is a market-capitalization-weighted index of the 500 largest publicly traded companies in the U.S. It is widely regarded as the best gauge of large-cap U.S. equities. Some of the la
Charting market cross currents, S&P 500 maintains 200-day average
04:47pm, Tuesday, 30'th Jun 2020
Technically speaking, the major U.S. benchmarks are poised to conclude June against an increasingly uneven, but still generally bullish, bigger-picture...
Dexcom Schedules Second Quarter 2020 Earnings Release and Conference Call for July 28, 2020 at 4:30 p.m. Eastern Time
12:45pm, Tuesday, 30'th Jun 2020
Dexcom Schedules Second Quarter 2020 Earnings Release and Conference Call for July 28, 2020 at 4:30 p.m. Eastern Time
Cloud Exposure: Looking Beyond The Benchmarks
11:44am, Tuesday, 30'th Jun 2020
The Nasdaq 100 currently holds only five companies in common with WCLD (Workday, Adobe, Zoom, PayPal and, recently, DocuSign), which together only amount to app
Dexcom Schedules Second Quarter 2020 Earnings Release and Conference Call for July 28, 2020 at 4:30 p.m. Eastern Time
12:00am, Tuesday, 30'th Jun 2020
Dexcom Schedules Second Quarter 2020 Earnings Release and Conference Call for July 28, 2020 at 4:30 p.m. Eastern Time
Enanta Pharmaceuticals Announces the Appointment of Mark G. Foletta to Its Board of Directors | | IT Business Net
12:02pm, Monday, 29'th Jun 2020
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases
Don't Buy Falling Financials, Buy These Stocks Instead
09:32pm, Friday, 26'th Jun 2020
Stress test results put the brakes on banking stocks. Healthcare and technology are better sectors for alpha-generating ideas. Top stocks to add to watch lists
Dow Jones Futures: Coronavirus Stock Market Rally Resilient As Tesla Leads Bullish Rebounds; Nike, JPMorgan, Goldman Move Late
12:23pm, Friday, 26'th Jun 2020
Stock Futures: The coronavirus stock market rally bounced back Thursday. So did Tesla and other leaders. DJIA stocks Nike, JPMorgan and Goldman Sachs moved late.
Zacks: Analysts Expect DexCom, Inc. (NASDAQ:DXCM) Will Post Earnings of $0.28 Per Share
01:20am, Friday, 26'th Jun 2020
Wall Street brokerages expect that DexCom, Inc. (NASDAQ:DXCM) will post earnings of $0.28 per share for the current fiscal quarter, Zacks Investment Research reports. Ten analysts have provided estima
Sign In
Buy DXCM